Cryo-Cell International Inc.

CCEL Healthcare Medical Care Facilities

Cryo-Cell International Inc.’s revenue for fiscal 2025 (year ended November 2025) was $31.6 million, down 1.31% from fiscal 2024.

Revenue
−0.02%
EPS
+77.8%
Free cash flow
−58.4%
Total debt
−29.5%

Quarter to August 2026, against a year earlier

4.97 0.02 +0.40%
Market cap
$39.9M
P/E
0.0×
Fwd P/E
65.1×
Dividend yield
0.00%
F-score
6/9
Altman Z
−0.23
Beneish M
−3.17
Dividend safety
20/100
Nov '16 Nov '17 Nov '18 Nov '19 Nov '20 Nov '21 Nov '22 Nov '23 Nov '24 Nov '25
P/E ratio
0.00 24.42 0.00 26.32 15.96 47.62 12.85 0.00 170.80 0.00
Piotroski F-Score
4 7 3 6 8 4 5 6 9 6
P/S ratio
1.49 2.24 1.87 1.85 1.82 3.49 1.22 1.42 2.17 1.02
Altman Z-Score
(0.32) 1.20 0.88 1.11 1.40 1.27 0.36 (0.72) 0.34 (0.23)
Altman Z″-Score (non-manufacturers)
(6.16) (2.62) (1.41) (1.07) 0.03 (0.95) (1.69) (4.39) (2.39) (3.07)
P/FCF ratio
7.42 10.13 11.66 10.83 7.06 103.33 0.00 34.84 32.44 8.24
Beneish M-Score
(4.04) (2.68) (2.72) (2.80) (2.94) (2.97) (2.70) (3.90) (2.75) (3.17)
P/Operating CF
13.45 26.96 64.73 52.34 19.01 60.41 15.23 13.34 32.19 25.07
Dividend Safety Score
— — — — — — — — — 20
P/B ratio
0.00 0.00 0.00 0.00 0.00 24.07 0.00 0.00 0.00 0.00
EV/Sales
1.65 2.19 1.97 1.80 1.68 3.30 1.52 1.70 2.43 1.24
EV/EBITDA
13.84 10.35 10.25 10.27 6.24 17.63 7.89 0.00 17.19 20.99
EV/FCF
8.22 9.88 12.28 10.54 6.53 97.67 (6.86) 41.61 36.33 10.08
Current Ratio
0.69 0.91 0.96 1.00 1.13 0.75 0.49 0.45 0.58 0.59
Net Debt/EBITDA
2.07 0.11 1.07 0.27 (0.50) (1.02) 1.56 (0.82) 1.84 3.83
Debt/Equity
(0.64) (0.58) (1.45) (1.29) (2.33) 0.67 (7.12) (0.87) (0.90) (0.56)
ROE
12.96% (16.59%) 7.98% (28.89%) (75.37%) 274.29% 208.38% 151.67% (3.32%) 15.27%
ROA
(6.77%) 10.66% (2.58%) 5.37% 8.14% 3.90% 4.41% (15.10%) 0.64% (3.84%)
ROIC
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 33.07% 0.00% 0.00% 0.00%
Return on Tangible Assets
42.33% (722.11%) (103.79%) 126.94% 95.83% (101.10%) 74.26% (99.33%) 3.13% (18.69%)
Average Days of Receivables
63.96 73.70 73.29 69.95 74.10 66.38 72.72 76.58 83.41 79.16
Earnings Yield
(4.79%) 4.09% (1.91%) 3.80% 6.27% 2.10% 7.78% (21.31%) 0.59% (7.79%)
Free Cash Flow Yield
13.47% 9.87% 8.58% 9.23% 14.17% 0.97% (18.18%) 2.87% 3.08% 12.13%
Free Cash Flow per Share
0.57 0.80 0.63 0.72 1.06 0.12 (0.79) 0.15 0.30 0.66
Book value per Share
(1.90) (1.77) (1.19) (0.89) (0.35) 0.51 (0.18) (1.32) (1.63) (2.31)
Free Cash Flow
4.65 5.62 4.69 5.63 8.02 0.97 (6.73) 1.28 2.41 5.36
EV/EBIT
88.04 11.09 11.09 11.31 6.83 23.70 11.46 0.00 22.35 81.46
Other line items

Show all line items

Columns are period end dates · fundamentals updated 2 Nov 2026